Capital Advisors Inc’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-215,921
Closed -$4.11M 202
2017
Q3
$4.11M Buy
215,921
+52,245
+32% +$1.08M 0.25% 87
2017
Q2
$3.94M Buy
163,676
+2,573
+2% +$56.4K 0.25% 86
2017
Q1
$3.19M Buy
+161,103
New +$3.6M 0.21% 85

Other funds holding PGEN

Capital Advisors Inc's PGEN Position: Q4 2017 in Review

Capital Advisors Inc sold out of Precigen (PGEN) in Q4 2017, closing a stake of 215,921 shares — an estimated $4.11M sold.

Capital Advisors Inc first reported a position in PGEN in Q1 2017 and held it in 3 quarters. The position peaked at $4.11M in Q3 2017. 162 funds tracked by Wall St. Rank hold PGEN as of Q4 2017.

  • Capital Advisors Inc reported no remaining Precigen position as of Q4 2017 after selling out during the quarter.
  • Capital Advisors Inc sold 215,921 Precigen shares in Q4 2017, an estimated $4.11M.
  • Capital Advisors Inc first reported a position in Precigen in Q1 2017 and held it in 3 quarters.
  • Capital Advisors Inc's Precigen position peaked at $4.11M in Q3 2017.
  • 162 funds tracked by Wall St. Rank held Precigen as of Q4 2017.

Based on Capital Advisors Inc's 13F filing for Q4 2017, filed 29 Jan 2018.